IMAJ personal page - To The Moon

IMAJ

IMAJ

me

7Follow

0Followers

0Topic

0Badge

2021-03-19

Buy..buy..buy

Toplines Before US Market Open on Friday

2021-03-19

Both are good

Better Pot Stock: Sundial Growers or Tilray?

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3577780775580322","uuid":"3577780775580322","gmtCreate":1614689628695,"gmtModify":1713008543041,"name":"IMAJ","pinyin":"imaj","introduction":"","introductionEn":"","signature":"me","avatar":"https://static.tigerbbs.com/7504d52324fe37c82c20a4371b45632a","hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","hatId":"ca_profile_frame_Mpy1eK","hatName":"","vip":1,"status":2,"fanSize":0,"headSize":7,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.96%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.95%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":350308953,"gmtCreate":1616157049272,"gmtModify":1704791639153,"author":{"id":"3577780775580322","authorId":"3577780775580322","name":"IMAJ","avatar":"https://static.tigerbbs.com/7504d52324fe37c82c20a4371b45632a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577780775580322","idStr":"3577780775580322"},"themes":[],"title":"","htmlText":"Buy..buy..buy","listText":"Buy..buy..buy","text":"Buy..buy..buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/350308953","repostId":"1114755564","repostType":4,"repost":{"id":"1114755564","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1616156989,"share":"https://ttm.financial/m/news/1114755564?lang=en_US&edition=fundamental","pubTime":"2021-03-19 20:29","market":"us","language":"en","title":"Toplines Before US Market Open on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1114755564","media":"Tiger Newspress","summary":"Stock futures rise, steadying after tech selloff.Nike, FedEx, Skillz, Ford & more making the biggest","content":"<ul><li>Stock futures rise, steadying after tech selloff.</li><li>Nike, FedEx, Skillz, Ford &amp; more&nbsp;making the biggest moves in the premarket.</li></ul><p>(March 19)&nbsp;Stock futures edged higher Friday morning to recover some losses from Thursday's session, when another technology-led selloff dragged on the three major indexes.</p><p>At 8:24 a.m. ET, Futures for the Dow Jones Industrial Average up 25 points to 32,790.00,&nbsp;while the Standard &amp; Poor’s 500 index futures rose 8 points at 3,914.00. Futures for the Nasdaq 100 index rose 59 points to 12,838.75.</p><p><img src=\"https://static.tigerbbs.com/3c1237210a3c58c82dd716380b12940e\" tg-width=\"349\" tg-height=\"145\" referrerpolicy=\"no-referrer\"></p><p>A day earlier, the Nasdaq slid by 3% for its worst session in three weeks as bond yields resurged. The 10-year Treasury yield spiked to the highest level since January 2020 and concerns over inflation reignited. The S&amp;P 500 fell 1.5%, and the Dow dropped 0.5%.</p><p><b>Stocks making the biggest moves in the premarket: Nike, FedEx, Skillz, Ford &amp; more</b></p><p>1)&nbsp;Nike(NKE) – Nike came in 14 cents a share above estimates, withquarterly profit of 90 cents per share. The athletic footwear and apparel company’s revenue came in below analysts’ projections, however, and its full-year revenue outlook was also shy of estimates. Nike said North American revenue was hit by port-related issues which delayed shipments by up to three weeks. Nike shares slid 3.2% in premarket trading.</p><p>2)&nbsp;FedEx(FDX) – FedExreported quarterly earnings of $3.47 per share, beating the consensus estimate of $3.23 a share. Revenue also came in above forecasts. FedEx’s average revenue per package for its Ground service rose by 11%, as it continues to benefit from the pandemic-related surge in e-commerce orders. Its shares jumped 4% in premarket action.</p><p>3)&nbsp;Skillz(SKLZ) – Skillz tumbled 7% in premarket action after the mobile gaming company announced a 32 million share public offering. The offering priced at $24 per share, with Skillz selling 17 million shares and certain stockholders selling the rest. Skillz said it would use the proceeds for general corporate purposes.</p><p>4)&nbsp;AstraZeneca(AZN) – AstraZeneca’s Covid-19 vaccine received the backing of Canada regulator Health Canada, which joined European countries in saying the vaccine is not linked to an increase in blood clots. Countries that had temporarily halted use of the vaccine have now resumed administering shots.</p><p>5)&nbsp;Hartford Financial(HIG) – The financial services company saidit is “carefully considering” a takeover proposalfrom insurance companyChubb(CB) for $65 per share or more than $23 billion. Hartford shares surged 18.7% Thursday following news of the offer, although it Is giving back about 1.4% in premarket trade.</p><p>6)&nbsp;Ollie’s Bargain Outlet(OLLI) – Ollie’s beat estimates by 14 cents a share, with quarterly earnings of 97 cents per share. The discount retailer’s revenue also came in above Wall Street forecasts. Comparable-store sales jumped 8.8%, beating the consensus FactSet forecast of a 3.2% increase. Ollie’s shares gained 4.6% in premarket trading.</p><p>7)&nbsp;Enphase(ENPH),SolarEdge Technologies(SEDG) – Susquehanna Financial upgraded both alternative energy stocks to “positive” from “neutral,” based on an anticipated expansion in solar installations in the years ahead and the strength of the two companies in the residential sector. Enphase rose 3.3% in the premarket, while SolarEdge gained 2.1%.</p><p>8)&nbsp;Ford Motor(F) – Ford shares are up 2.5% in premarket trading after Barclays upgraded the stock to “overweight” from “equal weight,” and increased its price target on the stock to $16 per share from $9. Barclays is encouraged by Ford’s developing electric vehicle strategy, among other factors.</p><p>9)&nbsp;Coherent(COHR) – The laser technology company remains on watch, as it mulls competing takeover bids fromLumentum(LITE) andII-VI(IIVI). Coherent first struck a deal to be acquired by Lumentum in January, but has received eight subsequent bids and revised offers since then.</p><p>10)&nbsp;Molson Coors(TAP) – The beer brewer’s stock fell 2.3% in premarket action after Deutsche Bank added it to its “short term sell catalyst” list. Deutsche Bank said the call is based on short-term concerns, including a material impact on first-quarter results from adverse February weather in Texas.</p><p>11)&nbsp;Petco Health(WOOF) – The pet supplies retailer was upgraded to “buy” from “neutral” at Bank of America Securities, saying Petco’s fourth-quarter results and 2021 were ahead of its expectations. The stock jumped 2.8% in premarket trading after losing 3.8% in Thursday trading.</p><p>12)&nbsp;Hims &amp; Hers Health(HIMS) – Hims &amp; Hers Health shares fell 3.3% in the premarket after the telehealth company reported a net quarterly loss of $3.1 million, even though that was smaller than the $12.4 million loss reported a year earlier. Revenue came in higher than anticipated, however, and total revenue was up by 80% for 2020.</p><p>13)&nbsp;Sarepta Therapeutics(SRPT) – The drugmaker’s shares rallied 5.4% in premarket trading after it reported upbeat results in a trial involving an experimental muscular dystrophy treatment.</p><p><b>Big&nbsp;News</b></p><p><b>1. Bond market rebels as it adjusts to Fed inflation polic</b></p><p>The10-year Treasury yieldpulled back Friday,one day after hitting a 14-month highof 1.754%.Traders revoltedover the Federal Reserve's willingness to let the economy and inflation to run hot as the job market recovers. Yields barely moved Wednesday afternoon after the Fed's meeting concluded, responding initially to the forecast for no rate hikes through 2023. The rapid rise in yields is being driven by concerns that more Covid stimulus on top of an already recovering economy will spark worrisome inflation. The 10-year yield started the year at less than 1%.</p><p><b>2. First U.S.-China meeting under Biden gets off to a rocky start</b></p><p>The first high-level meeting of U.S. and Chinese officials under the Biden administrationbegan with a flurry of insultsat a pre-meeting press event in Alaska on Thursday. The planned four-minute photo session for the officials to address reporters ended up lasting one hour and 15 minutes due to the frothy exchanges, according to NBC News. Expectations going in to the two-day talks, which are set to conclude Friday, were already low.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-19 20:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul><li>Stock futures rise, steadying after tech selloff.</li><li>Nike, FedEx, Skillz, Ford &amp; more&nbsp;making the biggest moves in the premarket.</li></ul><p>(March 19)&nbsp;Stock futures edged higher Friday morning to recover some losses from Thursday's session, when another technology-led selloff dragged on the three major indexes.</p><p>At 8:24 a.m. ET, Futures for the Dow Jones Industrial Average up 25 points to 32,790.00,&nbsp;while the Standard &amp; Poor’s 500 index futures rose 8 points at 3,914.00. Futures for the Nasdaq 100 index rose 59 points to 12,838.75.</p><p><img src=\"https://static.tigerbbs.com/3c1237210a3c58c82dd716380b12940e\" tg-width=\"349\" tg-height=\"145\" referrerpolicy=\"no-referrer\"></p><p>A day earlier, the Nasdaq slid by 3% for its worst session in three weeks as bond yields resurged. The 10-year Treasury yield spiked to the highest level since January 2020 and concerns over inflation reignited. The S&amp;P 500 fell 1.5%, and the Dow dropped 0.5%.</p><p><b>Stocks making the biggest moves in the premarket: Nike, FedEx, Skillz, Ford &amp; more</b></p><p>1)&nbsp;Nike(NKE) – Nike came in 14 cents a share above estimates, withquarterly profit of 90 cents per share. The athletic footwear and apparel company’s revenue came in below analysts’ projections, however, and its full-year revenue outlook was also shy of estimates. Nike said North American revenue was hit by port-related issues which delayed shipments by up to three weeks. Nike shares slid 3.2% in premarket trading.</p><p>2)&nbsp;FedEx(FDX) – FedExreported quarterly earnings of $3.47 per share, beating the consensus estimate of $3.23 a share. Revenue also came in above forecasts. FedEx’s average revenue per package for its Ground service rose by 11%, as it continues to benefit from the pandemic-related surge in e-commerce orders. Its shares jumped 4% in premarket action.</p><p>3)&nbsp;Skillz(SKLZ) – Skillz tumbled 7% in premarket action after the mobile gaming company announced a 32 million share public offering. The offering priced at $24 per share, with Skillz selling 17 million shares and certain stockholders selling the rest. Skillz said it would use the proceeds for general corporate purposes.</p><p>4)&nbsp;AstraZeneca(AZN) – AstraZeneca’s Covid-19 vaccine received the backing of Canada regulator Health Canada, which joined European countries in saying the vaccine is not linked to an increase in blood clots. Countries that had temporarily halted use of the vaccine have now resumed administering shots.</p><p>5)&nbsp;Hartford Financial(HIG) – The financial services company saidit is “carefully considering” a takeover proposalfrom insurance companyChubb(CB) for $65 per share or more than $23 billion. Hartford shares surged 18.7% Thursday following news of the offer, although it Is giving back about 1.4% in premarket trade.</p><p>6)&nbsp;Ollie’s Bargain Outlet(OLLI) – Ollie’s beat estimates by 14 cents a share, with quarterly earnings of 97 cents per share. The discount retailer’s revenue also came in above Wall Street forecasts. Comparable-store sales jumped 8.8%, beating the consensus FactSet forecast of a 3.2% increase. Ollie’s shares gained 4.6% in premarket trading.</p><p>7)&nbsp;Enphase(ENPH),SolarEdge Technologies(SEDG) – Susquehanna Financial upgraded both alternative energy stocks to “positive” from “neutral,” based on an anticipated expansion in solar installations in the years ahead and the strength of the two companies in the residential sector. Enphase rose 3.3% in the premarket, while SolarEdge gained 2.1%.</p><p>8)&nbsp;Ford Motor(F) – Ford shares are up 2.5% in premarket trading after Barclays upgraded the stock to “overweight” from “equal weight,” and increased its price target on the stock to $16 per share from $9. Barclays is encouraged by Ford’s developing electric vehicle strategy, among other factors.</p><p>9)&nbsp;Coherent(COHR) – The laser technology company remains on watch, as it mulls competing takeover bids fromLumentum(LITE) andII-VI(IIVI). Coherent first struck a deal to be acquired by Lumentum in January, but has received eight subsequent bids and revised offers since then.</p><p>10)&nbsp;Molson Coors(TAP) – The beer brewer’s stock fell 2.3% in premarket action after Deutsche Bank added it to its “short term sell catalyst” list. Deutsche Bank said the call is based on short-term concerns, including a material impact on first-quarter results from adverse February weather in Texas.</p><p>11)&nbsp;Petco Health(WOOF) – The pet supplies retailer was upgraded to “buy” from “neutral” at Bank of America Securities, saying Petco’s fourth-quarter results and 2021 were ahead of its expectations. The stock jumped 2.8% in premarket trading after losing 3.8% in Thursday trading.</p><p>12)&nbsp;Hims &amp; Hers Health(HIMS) – Hims &amp; Hers Health shares fell 3.3% in the premarket after the telehealth company reported a net quarterly loss of $3.1 million, even though that was smaller than the $12.4 million loss reported a year earlier. Revenue came in higher than anticipated, however, and total revenue was up by 80% for 2020.</p><p>13)&nbsp;Sarepta Therapeutics(SRPT) – The drugmaker’s shares rallied 5.4% in premarket trading after it reported upbeat results in a trial involving an experimental muscular dystrophy treatment.</p><p><b>Big&nbsp;News</b></p><p><b>1. Bond market rebels as it adjusts to Fed inflation polic</b></p><p>The10-year Treasury yieldpulled back Friday,one day after hitting a 14-month highof 1.754%.Traders revoltedover the Federal Reserve's willingness to let the economy and inflation to run hot as the job market recovers. Yields barely moved Wednesday afternoon after the Fed's meeting concluded, responding initially to the forecast for no rate hikes through 2023. The rapid rise in yields is being driven by concerns that more Covid stimulus on top of an already recovering economy will spark worrisome inflation. The 10-year yield started the year at less than 1%.</p><p><b>2. First U.S.-China meeting under Biden gets off to a rocky start</b></p><p>The first high-level meeting of U.S. and Chinese officials under the Biden administrationbegan with a flurry of insultsat a pre-meeting press event in Alaska on Thursday. The planned four-minute photo session for the officials to address reporters ended up lasting one hour and 15 minutes due to the frothy exchanges, according to NBC News. Expectations going in to the two-day talks, which are set to conclude Friday, were already low.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114755564","content_text":"Stock futures rise, steadying after tech selloff.Nike, FedEx, Skillz, Ford & more making the biggest moves in the premarket.(March 19) Stock futures edged higher Friday morning to recover some losses from Thursday's session, when another technology-led selloff dragged on the three major indexes.At 8:24 a.m. ET, Futures for the Dow Jones Industrial Average up 25 points to 32,790.00, while the Standard & Poor’s 500 index futures rose 8 points at 3,914.00. Futures for the Nasdaq 100 index rose 59 points to 12,838.75.A day earlier, the Nasdaq slid by 3% for its worst session in three weeks as bond yields resurged. The 10-year Treasury yield spiked to the highest level since January 2020 and concerns over inflation reignited. The S&P 500 fell 1.5%, and the Dow dropped 0.5%.Stocks making the biggest moves in the premarket: Nike, FedEx, Skillz, Ford & more1) Nike(NKE) – Nike came in 14 cents a share above estimates, withquarterly profit of 90 cents per share. The athletic footwear and apparel company’s revenue came in below analysts’ projections, however, and its full-year revenue outlook was also shy of estimates. Nike said North American revenue was hit by port-related issues which delayed shipments by up to three weeks. Nike shares slid 3.2% in premarket trading.2) FedEx(FDX) – FedExreported quarterly earnings of $3.47 per share, beating the consensus estimate of $3.23 a share. Revenue also came in above forecasts. FedEx’s average revenue per package for its Ground service rose by 11%, as it continues to benefit from the pandemic-related surge in e-commerce orders. Its shares jumped 4% in premarket action.3) Skillz(SKLZ) – Skillz tumbled 7% in premarket action after the mobile gaming company announced a 32 million share public offering. The offering priced at $24 per share, with Skillz selling 17 million shares and certain stockholders selling the rest. Skillz said it would use the proceeds for general corporate purposes.4) AstraZeneca(AZN) – AstraZeneca’s Covid-19 vaccine received the backing of Canada regulator Health Canada, which joined European countries in saying the vaccine is not linked to an increase in blood clots. Countries that had temporarily halted use of the vaccine have now resumed administering shots.5) Hartford Financial(HIG) – The financial services company saidit is “carefully considering” a takeover proposalfrom insurance companyChubb(CB) for $65 per share or more than $23 billion. Hartford shares surged 18.7% Thursday following news of the offer, although it Is giving back about 1.4% in premarket trade.6) Ollie’s Bargain Outlet(OLLI) – Ollie’s beat estimates by 14 cents a share, with quarterly earnings of 97 cents per share. The discount retailer’s revenue also came in above Wall Street forecasts. Comparable-store sales jumped 8.8%, beating the consensus FactSet forecast of a 3.2% increase. Ollie’s shares gained 4.6% in premarket trading.7) Enphase(ENPH),SolarEdge Technologies(SEDG) – Susquehanna Financial upgraded both alternative energy stocks to “positive” from “neutral,” based on an anticipated expansion in solar installations in the years ahead and the strength of the two companies in the residential sector. Enphase rose 3.3% in the premarket, while SolarEdge gained 2.1%.8) Ford Motor(F) – Ford shares are up 2.5% in premarket trading after Barclays upgraded the stock to “overweight” from “equal weight,” and increased its price target on the stock to $16 per share from $9. Barclays is encouraged by Ford’s developing electric vehicle strategy, among other factors.9) Coherent(COHR) – The laser technology company remains on watch, as it mulls competing takeover bids fromLumentum(LITE) andII-VI(IIVI). Coherent first struck a deal to be acquired by Lumentum in January, but has received eight subsequent bids and revised offers since then.10) Molson Coors(TAP) – The beer brewer’s stock fell 2.3% in premarket action after Deutsche Bank added it to its “short term sell catalyst” list. Deutsche Bank said the call is based on short-term concerns, including a material impact on first-quarter results from adverse February weather in Texas.11) Petco Health(WOOF) – The pet supplies retailer was upgraded to “buy” from “neutral” at Bank of America Securities, saying Petco’s fourth-quarter results and 2021 were ahead of its expectations. The stock jumped 2.8% in premarket trading after losing 3.8% in Thursday trading.12) Hims & Hers Health(HIMS) – Hims & Hers Health shares fell 3.3% in the premarket after the telehealth company reported a net quarterly loss of $3.1 million, even though that was smaller than the $12.4 million loss reported a year earlier. Revenue came in higher than anticipated, however, and total revenue was up by 80% for 2020.13) Sarepta Therapeutics(SRPT) – The drugmaker’s shares rallied 5.4% in premarket trading after it reported upbeat results in a trial involving an experimental muscular dystrophy treatment.Big News1. Bond market rebels as it adjusts to Fed inflation policThe10-year Treasury yieldpulled back Friday,one day after hitting a 14-month highof 1.754%.Traders revoltedover the Federal Reserve's willingness to let the economy and inflation to run hot as the job market recovers. Yields barely moved Wednesday afternoon after the Fed's meeting concluded, responding initially to the forecast for no rate hikes through 2023. The rapid rise in yields is being driven by concerns that more Covid stimulus on top of an already recovering economy will spark worrisome inflation. The 10-year yield started the year at less than 1%.2. First U.S.-China meeting under Biden gets off to a rocky startThe first high-level meeting of U.S. and Chinese officials under the Biden administrationbegan with a flurry of insultsat a pre-meeting press event in Alaska on Thursday. The planned four-minute photo session for the officials to address reporters ended up lasting one hour and 15 minutes due to the frothy exchanges, according to NBC News. Expectations going in to the two-day talks, which are set to conclude Friday, were already low.","news_type":1,"symbols_score_info":{".DJI":0.9,"SPY":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":1721,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":350303652,"gmtCreate":1616156913576,"gmtModify":1704791636885,"author":{"id":"3577780775580322","authorId":"3577780775580322","name":"IMAJ","avatar":"https://static.tigerbbs.com/7504d52324fe37c82c20a4371b45632a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577780775580322","idStr":"3577780775580322"},"themes":[],"title":"","htmlText":"Both are good","listText":"Both are good","text":"Both are good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/350303652","repostId":"1138846673","repostType":4,"repost":{"id":"1138846673","kind":"news","pubTimestamp":1616152403,"share":"https://ttm.financial/m/news/1138846673?lang=en_US&edition=fundamental","pubTime":"2021-03-19 19:13","market":"us","language":"en","title":"Better Pot Stock: Sundial Growers or Tilray?","url":"https://stock-news.laohu8.com/highlight/detail?id=1138846673","media":"Motley Fool","summary":"Here's how these two hot marijuana stocks compare.No cannabis stocks have attracted more attention i","content":"<blockquote>Here's how these two hot marijuana stocks compare.</blockquote><p>No cannabis stocks have attracted more attention in 2021 so far than<b>Sundial Growers</b>(NASDAQ:SNDL)and<b>Tilray</b>(NASDAQ:TLRY). That attention has been overwhelmingly positive, considering that the share prices for both companies have almost tripled year to date.</p><p>However, the excitement of being in the limelight can fade quickly. Which of these two pot stocks is the better pick going forward? Here's how Sundial and Tilray stack up against each other.</p><p><b>Growth</b></p><p>Tilray's revenuejumped 20.5% year over year in the fourth quarterto $56.6 million. The company's international medical cannabis sales skyrocketed 191%, while its Canadian adult-use recreational marijuana sales soared 49%. The only fly in the ointment for Tilray was its hemp segment, which experienced an 18% revenue decline.</p><p>Sundial announced its Q4 results on Wednesday, and its story wasn't nearly as good as Tilray's. The company reported net cannabis revenue of 13.9 million in Canadian dollars. While this reflected an 8% increase from the prior quarter, Sundial's revenue was down more than 5% year over year.</p><p>Both Sundial and Tilray have opportunities to grow in the Canadian market, especially as the country's Cannabis 2.0 derivatives market continues to pick up momentum. However, Tilray definitely will have an advantage.</p><p>Tilray's merger with<b>Aphria</b>(NASDAQ:APHA)is expected to close in the second quarter of 2021. The combined company will rank as the biggest global cannabis producer based on revenue. It will also claim the leading market share in the Canadian retail marijuana market.</p><p>The \"new\" Tilray will also be a top player in European medical cannabis markets because Aphria owns a major German cannabis wholesaler. Tilray also operates a large cannabis production facility in Portugal. Sundial doesn't have a presence in Europe at this point.</p><p>Tilray and Aphria also have businesses in the U.S., while Sundial doesn't. Aphria acquired craft-beer maker Sweetwater Brewing, and Tilray owns leading hemp foods manufacturer Manitoba Harvest. The combined company thinks that these operations will give it a great launching pad should federal cannabis reform open the door to jump into the lucrative U.S. cannabis market.</p><p><b>Financial position</b></p><p>Sundial posted a net loss of CA$64.1 million in the fourth quarter. The company generated an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) loss of CA$5.6 million and had CA$710 million in unrestricted cash as of March 15, 2021.</p><p>Tilray is in a much stronger financial position even before the Aphria merger. While the company recorded a Q4 net loss of $3 million, it was a huge improvement from the net loss of $219.8 million in the prior-year period. Tilray also generated positive adjusted EBITDA of $2.2 million and had $189.7 million in cash as of the end of 2020.</p><p>The financial situation for Tilray should improve once the Aphria merger closes. Aphria has delivered seven consecutive quarters of increasing adjusted EBITDA profitability. The combined entity expects to realize significant synergies within the two years following the finalization of the transaction.</p><p><b>Valuation</b></p><p>Tilray's market cap currently stands at around $4.5 billion, while Sundial's is close to $2.4 billion. But is Tilray actually worth nearly twice as much as Sundial?</p><p>We can't use earnings-based valuation metrics to compare the two stocks. However, Sundial and Tilray appear to be close using price-to-sales (P/S) ratios. Sundial currently trades at around 24 times trailing-12-month sales, while Tilray trades at a P/S multiple of nearly 23.</p><p>However, it's important to remember that Tilray's sales continue to rise year over year while Sundial's are still declining year over year. This makes Tilray's valuation more attractive compared to Sundial.</p><p><b>Better pot stock?</b></p><p>This decision isn't difficult. Tilray is growing faster than Sundial and seems to have stronger growth prospects going forward with the Aphria merger on the way. It claims a stronger financial position than Sundial and, to top things off, Tilray's valuation is slightly more attractive right now. On all counts, Tilray appears to be the better pot stock than Sundial.</p><p>However, I don't think that either of these stocks is a great choice for investors. There are several other stocks that are in a better position to profit from the U.S. cannabis market growth that are more attractively valued than either Sundial Growers or Tilray.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Better Pot Stock: Sundial Growers or Tilray?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBetter Pot Stock: Sundial Growers or Tilray?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-19 19:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/19/better-pot-stock-sundial-growers-or-tilray/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here's how these two hot marijuana stocks compare.No cannabis stocks have attracted more attention in 2021 so far thanSundial Growers(NASDAQ:SNDL)andTilray(NASDAQ:TLRY). That attention has been ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/19/better-pot-stock-sundial-growers-or-tilray/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/03/19/better-pot-stock-sundial-growers-or-tilray/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138846673","content_text":"Here's how these two hot marijuana stocks compare.No cannabis stocks have attracted more attention in 2021 so far thanSundial Growers(NASDAQ:SNDL)andTilray(NASDAQ:TLRY). That attention has been overwhelmingly positive, considering that the share prices for both companies have almost tripled year to date.However, the excitement of being in the limelight can fade quickly. Which of these two pot stocks is the better pick going forward? Here's how Sundial and Tilray stack up against each other.GrowthTilray's revenuejumped 20.5% year over year in the fourth quarterto $56.6 million. The company's international medical cannabis sales skyrocketed 191%, while its Canadian adult-use recreational marijuana sales soared 49%. The only fly in the ointment for Tilray was its hemp segment, which experienced an 18% revenue decline.Sundial announced its Q4 results on Wednesday, and its story wasn't nearly as good as Tilray's. The company reported net cannabis revenue of 13.9 million in Canadian dollars. While this reflected an 8% increase from the prior quarter, Sundial's revenue was down more than 5% year over year.Both Sundial and Tilray have opportunities to grow in the Canadian market, especially as the country's Cannabis 2.0 derivatives market continues to pick up momentum. However, Tilray definitely will have an advantage.Tilray's merger withAphria(NASDAQ:APHA)is expected to close in the second quarter of 2021. The combined company will rank as the biggest global cannabis producer based on revenue. It will also claim the leading market share in the Canadian retail marijuana market.The \"new\" Tilray will also be a top player in European medical cannabis markets because Aphria owns a major German cannabis wholesaler. Tilray also operates a large cannabis production facility in Portugal. Sundial doesn't have a presence in Europe at this point.Tilray and Aphria also have businesses in the U.S., while Sundial doesn't. Aphria acquired craft-beer maker Sweetwater Brewing, and Tilray owns leading hemp foods manufacturer Manitoba Harvest. The combined company thinks that these operations will give it a great launching pad should federal cannabis reform open the door to jump into the lucrative U.S. cannabis market.Financial positionSundial posted a net loss of CA$64.1 million in the fourth quarter. The company generated an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) loss of CA$5.6 million and had CA$710 million in unrestricted cash as of March 15, 2021.Tilray is in a much stronger financial position even before the Aphria merger. While the company recorded a Q4 net loss of $3 million, it was a huge improvement from the net loss of $219.8 million in the prior-year period. Tilray also generated positive adjusted EBITDA of $2.2 million and had $189.7 million in cash as of the end of 2020.The financial situation for Tilray should improve once the Aphria merger closes. Aphria has delivered seven consecutive quarters of increasing adjusted EBITDA profitability. The combined entity expects to realize significant synergies within the two years following the finalization of the transaction.ValuationTilray's market cap currently stands at around $4.5 billion, while Sundial's is close to $2.4 billion. But is Tilray actually worth nearly twice as much as Sundial?We can't use earnings-based valuation metrics to compare the two stocks. However, Sundial and Tilray appear to be close using price-to-sales (P/S) ratios. Sundial currently trades at around 24 times trailing-12-month sales, while Tilray trades at a P/S multiple of nearly 23.However, it's important to remember that Tilray's sales continue to rise year over year while Sundial's are still declining year over year. This makes Tilray's valuation more attractive compared to Sundial.Better pot stock?This decision isn't difficult. Tilray is growing faster than Sundial and seems to have stronger growth prospects going forward with the Aphria merger on the way. It claims a stronger financial position than Sundial and, to top things off, Tilray's valuation is slightly more attractive right now. On all counts, Tilray appears to be the better pot stock than Sundial.However, I don't think that either of these stocks is a great choice for investors. There are several other stocks that are in a better position to profit from the U.S. cannabis market growth that are more attractively valued than either Sundial Growers or Tilray.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1280,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":350308953,"gmtCreate":1616157049272,"gmtModify":1704791639153,"author":{"id":"3577780775580322","authorId":"3577780775580322","name":"IMAJ","avatar":"https://static.tigerbbs.com/7504d52324fe37c82c20a4371b45632a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577780775580322","authorIdStr":"3577780775580322"},"themes":[],"title":"","htmlText":"Buy..buy..buy","listText":"Buy..buy..buy","text":"Buy..buy..buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/350308953","repostId":"1114755564","repostType":4,"repost":{"id":"1114755564","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1616156989,"share":"https://ttm.financial/m/news/1114755564?lang=en_US&edition=fundamental","pubTime":"2021-03-19 20:29","market":"us","language":"en","title":"Toplines Before US Market Open on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1114755564","media":"Tiger Newspress","summary":"Stock futures rise, steadying after tech selloff.Nike, FedEx, Skillz, Ford & more making the biggest","content":"<ul><li>Stock futures rise, steadying after tech selloff.</li><li>Nike, FedEx, Skillz, Ford &amp; more&nbsp;making the biggest moves in the premarket.</li></ul><p>(March 19)&nbsp;Stock futures edged higher Friday morning to recover some losses from Thursday's session, when another technology-led selloff dragged on the three major indexes.</p><p>At 8:24 a.m. ET, Futures for the Dow Jones Industrial Average up 25 points to 32,790.00,&nbsp;while the Standard &amp; Poor’s 500 index futures rose 8 points at 3,914.00. Futures for the Nasdaq 100 index rose 59 points to 12,838.75.</p><p><img src=\"https://static.tigerbbs.com/3c1237210a3c58c82dd716380b12940e\" tg-width=\"349\" tg-height=\"145\" referrerpolicy=\"no-referrer\"></p><p>A day earlier, the Nasdaq slid by 3% for its worst session in three weeks as bond yields resurged. The 10-year Treasury yield spiked to the highest level since January 2020 and concerns over inflation reignited. The S&amp;P 500 fell 1.5%, and the Dow dropped 0.5%.</p><p><b>Stocks making the biggest moves in the premarket: Nike, FedEx, Skillz, Ford &amp; more</b></p><p>1)&nbsp;Nike(NKE) – Nike came in 14 cents a share above estimates, withquarterly profit of 90 cents per share. The athletic footwear and apparel company’s revenue came in below analysts’ projections, however, and its full-year revenue outlook was also shy of estimates. Nike said North American revenue was hit by port-related issues which delayed shipments by up to three weeks. Nike shares slid 3.2% in premarket trading.</p><p>2)&nbsp;FedEx(FDX) – FedExreported quarterly earnings of $3.47 per share, beating the consensus estimate of $3.23 a share. Revenue also came in above forecasts. FedEx’s average revenue per package for its Ground service rose by 11%, as it continues to benefit from the pandemic-related surge in e-commerce orders. Its shares jumped 4% in premarket action.</p><p>3)&nbsp;Skillz(SKLZ) – Skillz tumbled 7% in premarket action after the mobile gaming company announced a 32 million share public offering. The offering priced at $24 per share, with Skillz selling 17 million shares and certain stockholders selling the rest. Skillz said it would use the proceeds for general corporate purposes.</p><p>4)&nbsp;AstraZeneca(AZN) – AstraZeneca’s Covid-19 vaccine received the backing of Canada regulator Health Canada, which joined European countries in saying the vaccine is not linked to an increase in blood clots. Countries that had temporarily halted use of the vaccine have now resumed administering shots.</p><p>5)&nbsp;Hartford Financial(HIG) – The financial services company saidit is “carefully considering” a takeover proposalfrom insurance companyChubb(CB) for $65 per share or more than $23 billion. Hartford shares surged 18.7% Thursday following news of the offer, although it Is giving back about 1.4% in premarket trade.</p><p>6)&nbsp;Ollie’s Bargain Outlet(OLLI) – Ollie’s beat estimates by 14 cents a share, with quarterly earnings of 97 cents per share. The discount retailer’s revenue also came in above Wall Street forecasts. Comparable-store sales jumped 8.8%, beating the consensus FactSet forecast of a 3.2% increase. Ollie’s shares gained 4.6% in premarket trading.</p><p>7)&nbsp;Enphase(ENPH),SolarEdge Technologies(SEDG) – Susquehanna Financial upgraded both alternative energy stocks to “positive” from “neutral,” based on an anticipated expansion in solar installations in the years ahead and the strength of the two companies in the residential sector. Enphase rose 3.3% in the premarket, while SolarEdge gained 2.1%.</p><p>8)&nbsp;Ford Motor(F) – Ford shares are up 2.5% in premarket trading after Barclays upgraded the stock to “overweight” from “equal weight,” and increased its price target on the stock to $16 per share from $9. Barclays is encouraged by Ford’s developing electric vehicle strategy, among other factors.</p><p>9)&nbsp;Coherent(COHR) – The laser technology company remains on watch, as it mulls competing takeover bids fromLumentum(LITE) andII-VI(IIVI). Coherent first struck a deal to be acquired by Lumentum in January, but has received eight subsequent bids and revised offers since then.</p><p>10)&nbsp;Molson Coors(TAP) – The beer brewer’s stock fell 2.3% in premarket action after Deutsche Bank added it to its “short term sell catalyst” list. Deutsche Bank said the call is based on short-term concerns, including a material impact on first-quarter results from adverse February weather in Texas.</p><p>11)&nbsp;Petco Health(WOOF) – The pet supplies retailer was upgraded to “buy” from “neutral” at Bank of America Securities, saying Petco’s fourth-quarter results and 2021 were ahead of its expectations. The stock jumped 2.8% in premarket trading after losing 3.8% in Thursday trading.</p><p>12)&nbsp;Hims &amp; Hers Health(HIMS) – Hims &amp; Hers Health shares fell 3.3% in the premarket after the telehealth company reported a net quarterly loss of $3.1 million, even though that was smaller than the $12.4 million loss reported a year earlier. Revenue came in higher than anticipated, however, and total revenue was up by 80% for 2020.</p><p>13)&nbsp;Sarepta Therapeutics(SRPT) – The drugmaker’s shares rallied 5.4% in premarket trading after it reported upbeat results in a trial involving an experimental muscular dystrophy treatment.</p><p><b>Big&nbsp;News</b></p><p><b>1. Bond market rebels as it adjusts to Fed inflation polic</b></p><p>The10-year Treasury yieldpulled back Friday,one day after hitting a 14-month highof 1.754%.Traders revoltedover the Federal Reserve's willingness to let the economy and inflation to run hot as the job market recovers. Yields barely moved Wednesday afternoon after the Fed's meeting concluded, responding initially to the forecast for no rate hikes through 2023. The rapid rise in yields is being driven by concerns that more Covid stimulus on top of an already recovering economy will spark worrisome inflation. The 10-year yield started the year at less than 1%.</p><p><b>2. First U.S.-China meeting under Biden gets off to a rocky start</b></p><p>The first high-level meeting of U.S. and Chinese officials under the Biden administrationbegan with a flurry of insultsat a pre-meeting press event in Alaska on Thursday. The planned four-minute photo session for the officials to address reporters ended up lasting one hour and 15 minutes due to the frothy exchanges, according to NBC News. Expectations going in to the two-day talks, which are set to conclude Friday, were already low.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-19 20:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul><li>Stock futures rise, steadying after tech selloff.</li><li>Nike, FedEx, Skillz, Ford &amp; more&nbsp;making the biggest moves in the premarket.</li></ul><p>(March 19)&nbsp;Stock futures edged higher Friday morning to recover some losses from Thursday's session, when another technology-led selloff dragged on the three major indexes.</p><p>At 8:24 a.m. ET, Futures for the Dow Jones Industrial Average up 25 points to 32,790.00,&nbsp;while the Standard &amp; Poor’s 500 index futures rose 8 points at 3,914.00. Futures for the Nasdaq 100 index rose 59 points to 12,838.75.</p><p><img src=\"https://static.tigerbbs.com/3c1237210a3c58c82dd716380b12940e\" tg-width=\"349\" tg-height=\"145\" referrerpolicy=\"no-referrer\"></p><p>A day earlier, the Nasdaq slid by 3% for its worst session in three weeks as bond yields resurged. The 10-year Treasury yield spiked to the highest level since January 2020 and concerns over inflation reignited. The S&amp;P 500 fell 1.5%, and the Dow dropped 0.5%.</p><p><b>Stocks making the biggest moves in the premarket: Nike, FedEx, Skillz, Ford &amp; more</b></p><p>1)&nbsp;Nike(NKE) – Nike came in 14 cents a share above estimates, withquarterly profit of 90 cents per share. The athletic footwear and apparel company’s revenue came in below analysts’ projections, however, and its full-year revenue outlook was also shy of estimates. Nike said North American revenue was hit by port-related issues which delayed shipments by up to three weeks. Nike shares slid 3.2% in premarket trading.</p><p>2)&nbsp;FedEx(FDX) – FedExreported quarterly earnings of $3.47 per share, beating the consensus estimate of $3.23 a share. Revenue also came in above forecasts. FedEx’s average revenue per package for its Ground service rose by 11%, as it continues to benefit from the pandemic-related surge in e-commerce orders. Its shares jumped 4% in premarket action.</p><p>3)&nbsp;Skillz(SKLZ) – Skillz tumbled 7% in premarket action after the mobile gaming company announced a 32 million share public offering. The offering priced at $24 per share, with Skillz selling 17 million shares and certain stockholders selling the rest. Skillz said it would use the proceeds for general corporate purposes.</p><p>4)&nbsp;AstraZeneca(AZN) – AstraZeneca’s Covid-19 vaccine received the backing of Canada regulator Health Canada, which joined European countries in saying the vaccine is not linked to an increase in blood clots. Countries that had temporarily halted use of the vaccine have now resumed administering shots.</p><p>5)&nbsp;Hartford Financial(HIG) – The financial services company saidit is “carefully considering” a takeover proposalfrom insurance companyChubb(CB) for $65 per share or more than $23 billion. Hartford shares surged 18.7% Thursday following news of the offer, although it Is giving back about 1.4% in premarket trade.</p><p>6)&nbsp;Ollie’s Bargain Outlet(OLLI) – Ollie’s beat estimates by 14 cents a share, with quarterly earnings of 97 cents per share. The discount retailer’s revenue also came in above Wall Street forecasts. Comparable-store sales jumped 8.8%, beating the consensus FactSet forecast of a 3.2% increase. Ollie’s shares gained 4.6% in premarket trading.</p><p>7)&nbsp;Enphase(ENPH),SolarEdge Technologies(SEDG) – Susquehanna Financial upgraded both alternative energy stocks to “positive” from “neutral,” based on an anticipated expansion in solar installations in the years ahead and the strength of the two companies in the residential sector. Enphase rose 3.3% in the premarket, while SolarEdge gained 2.1%.</p><p>8)&nbsp;Ford Motor(F) – Ford shares are up 2.5% in premarket trading after Barclays upgraded the stock to “overweight” from “equal weight,” and increased its price target on the stock to $16 per share from $9. Barclays is encouraged by Ford’s developing electric vehicle strategy, among other factors.</p><p>9)&nbsp;Coherent(COHR) – The laser technology company remains on watch, as it mulls competing takeover bids fromLumentum(LITE) andII-VI(IIVI). Coherent first struck a deal to be acquired by Lumentum in January, but has received eight subsequent bids and revised offers since then.</p><p>10)&nbsp;Molson Coors(TAP) – The beer brewer’s stock fell 2.3% in premarket action after Deutsche Bank added it to its “short term sell catalyst” list. Deutsche Bank said the call is based on short-term concerns, including a material impact on first-quarter results from adverse February weather in Texas.</p><p>11)&nbsp;Petco Health(WOOF) – The pet supplies retailer was upgraded to “buy” from “neutral” at Bank of America Securities, saying Petco’s fourth-quarter results and 2021 were ahead of its expectations. The stock jumped 2.8% in premarket trading after losing 3.8% in Thursday trading.</p><p>12)&nbsp;Hims &amp; Hers Health(HIMS) – Hims &amp; Hers Health shares fell 3.3% in the premarket after the telehealth company reported a net quarterly loss of $3.1 million, even though that was smaller than the $12.4 million loss reported a year earlier. Revenue came in higher than anticipated, however, and total revenue was up by 80% for 2020.</p><p>13)&nbsp;Sarepta Therapeutics(SRPT) – The drugmaker’s shares rallied 5.4% in premarket trading after it reported upbeat results in a trial involving an experimental muscular dystrophy treatment.</p><p><b>Big&nbsp;News</b></p><p><b>1. Bond market rebels as it adjusts to Fed inflation polic</b></p><p>The10-year Treasury yieldpulled back Friday,one day after hitting a 14-month highof 1.754%.Traders revoltedover the Federal Reserve's willingness to let the economy and inflation to run hot as the job market recovers. Yields barely moved Wednesday afternoon after the Fed's meeting concluded, responding initially to the forecast for no rate hikes through 2023. The rapid rise in yields is being driven by concerns that more Covid stimulus on top of an already recovering economy will spark worrisome inflation. The 10-year yield started the year at less than 1%.</p><p><b>2. First U.S.-China meeting under Biden gets off to a rocky start</b></p><p>The first high-level meeting of U.S. and Chinese officials under the Biden administrationbegan with a flurry of insultsat a pre-meeting press event in Alaska on Thursday. The planned four-minute photo session for the officials to address reporters ended up lasting one hour and 15 minutes due to the frothy exchanges, according to NBC News. Expectations going in to the two-day talks, which are set to conclude Friday, were already low.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114755564","content_text":"Stock futures rise, steadying after tech selloff.Nike, FedEx, Skillz, Ford & more making the biggest moves in the premarket.(March 19) Stock futures edged higher Friday morning to recover some losses from Thursday's session, when another technology-led selloff dragged on the three major indexes.At 8:24 a.m. ET, Futures for the Dow Jones Industrial Average up 25 points to 32,790.00, while the Standard & Poor’s 500 index futures rose 8 points at 3,914.00. Futures for the Nasdaq 100 index rose 59 points to 12,838.75.A day earlier, the Nasdaq slid by 3% for its worst session in three weeks as bond yields resurged. The 10-year Treasury yield spiked to the highest level since January 2020 and concerns over inflation reignited. The S&P 500 fell 1.5%, and the Dow dropped 0.5%.Stocks making the biggest moves in the premarket: Nike, FedEx, Skillz, Ford & more1) Nike(NKE) – Nike came in 14 cents a share above estimates, withquarterly profit of 90 cents per share. The athletic footwear and apparel company’s revenue came in below analysts’ projections, however, and its full-year revenue outlook was also shy of estimates. Nike said North American revenue was hit by port-related issues which delayed shipments by up to three weeks. Nike shares slid 3.2% in premarket trading.2) FedEx(FDX) – FedExreported quarterly earnings of $3.47 per share, beating the consensus estimate of $3.23 a share. Revenue also came in above forecasts. FedEx’s average revenue per package for its Ground service rose by 11%, as it continues to benefit from the pandemic-related surge in e-commerce orders. Its shares jumped 4% in premarket action.3) Skillz(SKLZ) – Skillz tumbled 7% in premarket action after the mobile gaming company announced a 32 million share public offering. The offering priced at $24 per share, with Skillz selling 17 million shares and certain stockholders selling the rest. Skillz said it would use the proceeds for general corporate purposes.4) AstraZeneca(AZN) – AstraZeneca’s Covid-19 vaccine received the backing of Canada regulator Health Canada, which joined European countries in saying the vaccine is not linked to an increase in blood clots. Countries that had temporarily halted use of the vaccine have now resumed administering shots.5) Hartford Financial(HIG) – The financial services company saidit is “carefully considering” a takeover proposalfrom insurance companyChubb(CB) for $65 per share or more than $23 billion. Hartford shares surged 18.7% Thursday following news of the offer, although it Is giving back about 1.4% in premarket trade.6) Ollie’s Bargain Outlet(OLLI) – Ollie’s beat estimates by 14 cents a share, with quarterly earnings of 97 cents per share. The discount retailer’s revenue also came in above Wall Street forecasts. Comparable-store sales jumped 8.8%, beating the consensus FactSet forecast of a 3.2% increase. Ollie’s shares gained 4.6% in premarket trading.7) Enphase(ENPH),SolarEdge Technologies(SEDG) – Susquehanna Financial upgraded both alternative energy stocks to “positive” from “neutral,” based on an anticipated expansion in solar installations in the years ahead and the strength of the two companies in the residential sector. Enphase rose 3.3% in the premarket, while SolarEdge gained 2.1%.8) Ford Motor(F) – Ford shares are up 2.5% in premarket trading after Barclays upgraded the stock to “overweight” from “equal weight,” and increased its price target on the stock to $16 per share from $9. Barclays is encouraged by Ford’s developing electric vehicle strategy, among other factors.9) Coherent(COHR) – The laser technology company remains on watch, as it mulls competing takeover bids fromLumentum(LITE) andII-VI(IIVI). Coherent first struck a deal to be acquired by Lumentum in January, but has received eight subsequent bids and revised offers since then.10) Molson Coors(TAP) – The beer brewer’s stock fell 2.3% in premarket action after Deutsche Bank added it to its “short term sell catalyst” list. Deutsche Bank said the call is based on short-term concerns, including a material impact on first-quarter results from adverse February weather in Texas.11) Petco Health(WOOF) – The pet supplies retailer was upgraded to “buy” from “neutral” at Bank of America Securities, saying Petco’s fourth-quarter results and 2021 were ahead of its expectations. The stock jumped 2.8% in premarket trading after losing 3.8% in Thursday trading.12) Hims & Hers Health(HIMS) – Hims & Hers Health shares fell 3.3% in the premarket after the telehealth company reported a net quarterly loss of $3.1 million, even though that was smaller than the $12.4 million loss reported a year earlier. Revenue came in higher than anticipated, however, and total revenue was up by 80% for 2020.13) Sarepta Therapeutics(SRPT) – The drugmaker’s shares rallied 5.4% in premarket trading after it reported upbeat results in a trial involving an experimental muscular dystrophy treatment.Big News1. Bond market rebels as it adjusts to Fed inflation policThe10-year Treasury yieldpulled back Friday,one day after hitting a 14-month highof 1.754%.Traders revoltedover the Federal Reserve's willingness to let the economy and inflation to run hot as the job market recovers. Yields barely moved Wednesday afternoon after the Fed's meeting concluded, responding initially to the forecast for no rate hikes through 2023. The rapid rise in yields is being driven by concerns that more Covid stimulus on top of an already recovering economy will spark worrisome inflation. The 10-year yield started the year at less than 1%.2. First U.S.-China meeting under Biden gets off to a rocky startThe first high-level meeting of U.S. and Chinese officials under the Biden administrationbegan with a flurry of insultsat a pre-meeting press event in Alaska on Thursday. The planned four-minute photo session for the officials to address reporters ended up lasting one hour and 15 minutes due to the frothy exchanges, according to NBC News. Expectations going in to the two-day talks, which are set to conclude Friday, were already low.","news_type":1,"symbols_score_info":{".DJI":0.9,"SPY":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":1721,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":350303652,"gmtCreate":1616156913576,"gmtModify":1704791636885,"author":{"id":"3577780775580322","authorId":"3577780775580322","name":"IMAJ","avatar":"https://static.tigerbbs.com/7504d52324fe37c82c20a4371b45632a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577780775580322","authorIdStr":"3577780775580322"},"themes":[],"title":"","htmlText":"Both are good","listText":"Both are good","text":"Both are good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/350303652","repostId":"1138846673","repostType":4,"repost":{"id":"1138846673","kind":"news","pubTimestamp":1616152403,"share":"https://ttm.financial/m/news/1138846673?lang=en_US&edition=fundamental","pubTime":"2021-03-19 19:13","market":"us","language":"en","title":"Better Pot Stock: Sundial Growers or Tilray?","url":"https://stock-news.laohu8.com/highlight/detail?id=1138846673","media":"Motley Fool","summary":"Here's how these two hot marijuana stocks compare.No cannabis stocks have attracted more attention i","content":"<blockquote>Here's how these two hot marijuana stocks compare.</blockquote><p>No cannabis stocks have attracted more attention in 2021 so far than<b>Sundial Growers</b>(NASDAQ:SNDL)and<b>Tilray</b>(NASDAQ:TLRY). That attention has been overwhelmingly positive, considering that the share prices for both companies have almost tripled year to date.</p><p>However, the excitement of being in the limelight can fade quickly. Which of these two pot stocks is the better pick going forward? Here's how Sundial and Tilray stack up against each other.</p><p><b>Growth</b></p><p>Tilray's revenuejumped 20.5% year over year in the fourth quarterto $56.6 million. The company's international medical cannabis sales skyrocketed 191%, while its Canadian adult-use recreational marijuana sales soared 49%. The only fly in the ointment for Tilray was its hemp segment, which experienced an 18% revenue decline.</p><p>Sundial announced its Q4 results on Wednesday, and its story wasn't nearly as good as Tilray's. The company reported net cannabis revenue of 13.9 million in Canadian dollars. While this reflected an 8% increase from the prior quarter, Sundial's revenue was down more than 5% year over year.</p><p>Both Sundial and Tilray have opportunities to grow in the Canadian market, especially as the country's Cannabis 2.0 derivatives market continues to pick up momentum. However, Tilray definitely will have an advantage.</p><p>Tilray's merger with<b>Aphria</b>(NASDAQ:APHA)is expected to close in the second quarter of 2021. The combined company will rank as the biggest global cannabis producer based on revenue. It will also claim the leading market share in the Canadian retail marijuana market.</p><p>The \"new\" Tilray will also be a top player in European medical cannabis markets because Aphria owns a major German cannabis wholesaler. Tilray also operates a large cannabis production facility in Portugal. Sundial doesn't have a presence in Europe at this point.</p><p>Tilray and Aphria also have businesses in the U.S., while Sundial doesn't. Aphria acquired craft-beer maker Sweetwater Brewing, and Tilray owns leading hemp foods manufacturer Manitoba Harvest. The combined company thinks that these operations will give it a great launching pad should federal cannabis reform open the door to jump into the lucrative U.S. cannabis market.</p><p><b>Financial position</b></p><p>Sundial posted a net loss of CA$64.1 million in the fourth quarter. The company generated an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) loss of CA$5.6 million and had CA$710 million in unrestricted cash as of March 15, 2021.</p><p>Tilray is in a much stronger financial position even before the Aphria merger. While the company recorded a Q4 net loss of $3 million, it was a huge improvement from the net loss of $219.8 million in the prior-year period. Tilray also generated positive adjusted EBITDA of $2.2 million and had $189.7 million in cash as of the end of 2020.</p><p>The financial situation for Tilray should improve once the Aphria merger closes. Aphria has delivered seven consecutive quarters of increasing adjusted EBITDA profitability. The combined entity expects to realize significant synergies within the two years following the finalization of the transaction.</p><p><b>Valuation</b></p><p>Tilray's market cap currently stands at around $4.5 billion, while Sundial's is close to $2.4 billion. But is Tilray actually worth nearly twice as much as Sundial?</p><p>We can't use earnings-based valuation metrics to compare the two stocks. However, Sundial and Tilray appear to be close using price-to-sales (P/S) ratios. Sundial currently trades at around 24 times trailing-12-month sales, while Tilray trades at a P/S multiple of nearly 23.</p><p>However, it's important to remember that Tilray's sales continue to rise year over year while Sundial's are still declining year over year. This makes Tilray's valuation more attractive compared to Sundial.</p><p><b>Better pot stock?</b></p><p>This decision isn't difficult. Tilray is growing faster than Sundial and seems to have stronger growth prospects going forward with the Aphria merger on the way. It claims a stronger financial position than Sundial and, to top things off, Tilray's valuation is slightly more attractive right now. On all counts, Tilray appears to be the better pot stock than Sundial.</p><p>However, I don't think that either of these stocks is a great choice for investors. There are several other stocks that are in a better position to profit from the U.S. cannabis market growth that are more attractively valued than either Sundial Growers or Tilray.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Better Pot Stock: Sundial Growers or Tilray?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBetter Pot Stock: Sundial Growers or Tilray?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-19 19:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/19/better-pot-stock-sundial-growers-or-tilray/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here's how these two hot marijuana stocks compare.No cannabis stocks have attracted more attention in 2021 so far thanSundial Growers(NASDAQ:SNDL)andTilray(NASDAQ:TLRY). That attention has been ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/19/better-pot-stock-sundial-growers-or-tilray/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/03/19/better-pot-stock-sundial-growers-or-tilray/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138846673","content_text":"Here's how these two hot marijuana stocks compare.No cannabis stocks have attracted more attention in 2021 so far thanSundial Growers(NASDAQ:SNDL)andTilray(NASDAQ:TLRY). That attention has been overwhelmingly positive, considering that the share prices for both companies have almost tripled year to date.However, the excitement of being in the limelight can fade quickly. Which of these two pot stocks is the better pick going forward? Here's how Sundial and Tilray stack up against each other.GrowthTilray's revenuejumped 20.5% year over year in the fourth quarterto $56.6 million. The company's international medical cannabis sales skyrocketed 191%, while its Canadian adult-use recreational marijuana sales soared 49%. The only fly in the ointment for Tilray was its hemp segment, which experienced an 18% revenue decline.Sundial announced its Q4 results on Wednesday, and its story wasn't nearly as good as Tilray's. The company reported net cannabis revenue of 13.9 million in Canadian dollars. While this reflected an 8% increase from the prior quarter, Sundial's revenue was down more than 5% year over year.Both Sundial and Tilray have opportunities to grow in the Canadian market, especially as the country's Cannabis 2.0 derivatives market continues to pick up momentum. However, Tilray definitely will have an advantage.Tilray's merger withAphria(NASDAQ:APHA)is expected to close in the second quarter of 2021. The combined company will rank as the biggest global cannabis producer based on revenue. It will also claim the leading market share in the Canadian retail marijuana market.The \"new\" Tilray will also be a top player in European medical cannabis markets because Aphria owns a major German cannabis wholesaler. Tilray also operates a large cannabis production facility in Portugal. Sundial doesn't have a presence in Europe at this point.Tilray and Aphria also have businesses in the U.S., while Sundial doesn't. Aphria acquired craft-beer maker Sweetwater Brewing, and Tilray owns leading hemp foods manufacturer Manitoba Harvest. The combined company thinks that these operations will give it a great launching pad should federal cannabis reform open the door to jump into the lucrative U.S. cannabis market.Financial positionSundial posted a net loss of CA$64.1 million in the fourth quarter. The company generated an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) loss of CA$5.6 million and had CA$710 million in unrestricted cash as of March 15, 2021.Tilray is in a much stronger financial position even before the Aphria merger. While the company recorded a Q4 net loss of $3 million, it was a huge improvement from the net loss of $219.8 million in the prior-year period. Tilray also generated positive adjusted EBITDA of $2.2 million and had $189.7 million in cash as of the end of 2020.The financial situation for Tilray should improve once the Aphria merger closes. Aphria has delivered seven consecutive quarters of increasing adjusted EBITDA profitability. The combined entity expects to realize significant synergies within the two years following the finalization of the transaction.ValuationTilray's market cap currently stands at around $4.5 billion, while Sundial's is close to $2.4 billion. But is Tilray actually worth nearly twice as much as Sundial?We can't use earnings-based valuation metrics to compare the two stocks. However, Sundial and Tilray appear to be close using price-to-sales (P/S) ratios. Sundial currently trades at around 24 times trailing-12-month sales, while Tilray trades at a P/S multiple of nearly 23.However, it's important to remember that Tilray's sales continue to rise year over year while Sundial's are still declining year over year. This makes Tilray's valuation more attractive compared to Sundial.Better pot stock?This decision isn't difficult. Tilray is growing faster than Sundial and seems to have stronger growth prospects going forward with the Aphria merger on the way. It claims a stronger financial position than Sundial and, to top things off, Tilray's valuation is slightly more attractive right now. On all counts, Tilray appears to be the better pot stock than Sundial.However, I don't think that either of these stocks is a great choice for investors. There are several other stocks that are in a better position to profit from the U.S. cannabis market growth that are more attractively valued than either Sundial Growers or Tilray.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1280,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}